Name: Drug Compounding. Background, Issues & FDA Oversight
SKU: 64756007
Price: 193.81 USD
Availability: InStock
Author: Martti Bram
ISBN: 9781631173608

portada Drug Compounding. Background, Issues & FDA Oversight

Drug Compounding. Background, Issues & FDA Oversight

Formato

Libro Físico

Editorial

Nova Science Publishers

Autor

Martti Bram

Año

2014

N° páginas

123

Encuadernación

Tapa Dura

Dimensiones

23.8x15.7x1.5 cm

ISBN13

9781631173608

Drug Compounding. Background, Issues & FDA Oversight

Martti Bram (Autor) · Nova Science Publishers · Tapa Dura

Libro Nuevo Importado

Envío: 16 a 23 días háb.

$ 323.01$ 193.81

-40%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Última Unidad

$ 193.81

Llega entre el 19 Oct y el 30 Oct a Quito, Pichincha. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Drug Compounding. Background, Issues & FDA Oversight"

Compounding has been traditionally defined as a process where a pharmacist or a physician combines, mixes, or alters ingredients to create a medication tailored to the needs of an individual patient. Traditionally compounded drugs (CDs) are made in response to an individual prescription from a licensed health provider in the context of a pharmacist''s and health care professional''s relationship with a specific patient. This book provides background information on CDs and non-traditional compounding pharmacies relevant to policy discussions. This book will also examine the FDA''s regulation of drug compounding and will discuss relevant legal authorities. Specifically, the status of FDA''s authority to oversee drug compounding, and the gaps, if any, between state and federal authority will be discussed, as well as how FDA has used its data and authority to oversee drug compounding, and the actions taken or planned by states or national pharmacy organisations to improve oversight of drug compounding.